Q1 EPS Forecast for Ionis Pharmaceuticals Cut by Analyst
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) – Stock analysts at Leerink Partnrs lowered their Q1 2025 earnings estimates for Ionis Pharmaceuticals in a research report issued on Wednesday, April 16th. Leerink Partnrs analyst M. Foroohar now forecasts that the company will post earnings of ($1.21) per share for the quarter, down from their prior […]
